Larvol Delta - Positive-Phase-1-Clinical-Data-of-MTX110-in-DMG-Brain-Cancer-Demonstrating-Increased-Survival-Presented-at-ISPNO-2024

panobinostat (MTX110) - Biodexa Pharma

https://www.globenewswire.com/news-release/2024/07/02/2907388/0/en/Positive-Phase-1-Clinical-Data-of-MTX110-in-DMG-Brain-Cancer-Demonstrating-Increased-Survival-Presented-at-ISPNO-2024.html

Jul 2, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next